Top News

Jan 24, 2018
By BioPharm International Editors
The acquisition would boost Sanofi's position in hematology and specialty medicines.
Jan 23, 2018
By BioPharm International Editors
The latest continuing resolution funds the government for three weeks.
Jan 22, 2018
By BioPharm International Editors
Non-essential activities and new regulatory submissions are on hold until a federal government funding agreement is reached.
Jan 19, 2018
By BioPharm International Editors
Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.
Jan 05, 2018
By BioPharm International Editors
FDA Commissioner Gottlieb expects that the saline and amino acid drug shortages from Puerto Rican manufacturing facilities will improve in the early part of 2018.
Dec 20, 2017
New tax legislation may result in savings for biopharma companies.
Dec 18, 2017
By BioPharm International Editors
The US Court of Appeals for the Federal Circuit has decided in favor of Novartis’ Sandoz in rendering the opinion that Amgen cannot use state laws to prohibit or delay the marketing of biosimilars.
Dec 05, 2017
By BioPharm International Editors
Biopharma majors are among the industry stakeholders who have commented and raised questions about FDA’s recently proposed draft guidance for analytical assessment of similarity in biosimilars.
Nov 21, 2017
By BioPharm International Editors
Following a vote by member states in favor of Amsterdam as the agency’s new headquarters, the relocation will take place over the next 16 months, with operations expected to start up in March 2019.
Oct 31, 2017
By BioPharm International Editors
A mutual recognition agreement to accept inspection data from eight EU regulatory authorities may reduce inspection burdens at global drug facilities.
native1_300x100
lorem ipsum